Therapeutic cell encapsulation techniques and applications in diabetes

Advanced Drug Delivery Reviews

Volumn 67-68, Issue , 2014, Pages 74-83

  Steele, J A M ^a,b   Halle J P ^c   Poncelet, D ^d   Neufeld, R J ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^d LUNAM UNIVERSITÉ   (France)

Author keywords

Bioencapsulation; Immunoisolation; Islets; Microcapsules

Indexed keywords

CELLS; CYTOLOGY;

BIOENCAPSULATION; CELL ENCAPSULATIONS; IMMUNO-ISOLATION; ISLETS; MICROCAPSULES; PANCREATIC CELLS; PHYSIOLOGICAL PROCESS; XENOGENEIC CELLS;

ENCAPSULATION;

ALGINIC ACID; EMULSION; GLUCURONIC ACID; HEXURONIC ACID;

ANATOMY AND HISTOLOGY; ANIMAL; CHEMISTRY; DIABETES MELLITUS, TYPE 1; EMULSION; HUMAN; PANCREAS; PANCREAS ISLET TRANSPLANTATION; PANCREAS TRANSPLANTATION; PROCEDURES; STATIC ELECTRICITY; TISSUE SCAFFOLD;

ALGINATES; ANIMALS; DIABETES MELLITUS, TYPE 1; EMULSIONS; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; PANCREAS; PANCREAS TRANSPLANTATION; STATIC ELECTRICITY; TISSUE SCAFFOLDS;

EID: 84898542190     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2013.09.015     Document Type: Review

References (95)

1. Martini F.H., Timmons M.J., Tallistch R.B. Human Anatomy 2008, 518-519. Pearson Education Inc., Toronto, (685-686). sixth ed.
2. Hallé J.-P., de Vos P. The Need for New Therapeutic Approaches and the Bioartificial Endocrine Pancreas. The Bioartificial Pancreas and Other Biohybrid Techniques 2009, 1-26. Transworld Research Network, Kerala, India. J.P. Hallé, P. de Vos, L. Rosenberg (Eds.).
3. Perez-Basterrechea M., Briones R.M., Alvarez-Viejo M., Garcia-Perez E., Esteban M.M., Garcia V., Obaya A., Barneo L., Meana A., Otero J. Plasma-fibroblast gel as scaffold for islet transplantation. Tissue Eng. A 2009, 15(3):569-577.
4. Elliot R.B., Escobar L., Tan P.L.J., Muzina M., Zwain S., Buchanan C. Live encapsulated porcine islets from a type 1 diabetic patient 9.5yr after xenotransplantation. Xenotransplantation 2007, 14:157-161.
5. Brendenburg D. History and diagnostic significance of C-peptide. Exp. Diabetes Res. 2008, 2008(576862):1-7. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2396242). 10.1155/2008/576862.
6. Williams M.E., Lacson E., Teng M., Ofsthun N., Lazarus J.M. Hemodialyzed type I and type II diabetic patients in the US: characteristics, glycemic control, and survival. Kidney Int. 2006, 70:1503-1509.
7. Canadian Diabetes Association Diabetes: Canada at the Tipping Point http://www.diabetes.ca/documents/get-involved/WEB_Eng.CDA_Report_.pdf.
8. Skarulis M.C., Hirshberg B. Hypoglycemia in the Adult. Diabetes Mellitus: A Fundamental and Clinical Text 2004, 1427-1438. Lippincott Williams & Wilkins, Philadelphia. D. LeRoith, S.I. Taylor, J.M. Olefski (Eds.).
9. Kobayashi N. Bioartificial pancreas for the treatment of diabetes. Cell Trans. 2008, 17:11-17.
10. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 1993, 329:977-986.
11. Canadian Diabetes Association The Prevalence and Cost of Diabetes April 2008, (http://www.diabetes.ca/Files/prevalence-and-costs.pdf. Accessed May 24, 2011).
12. Williams P.W. Notes on diabetes treated with extract and by grafts of sheep's pancreas. BMJ 1894, 2:1303-1304.
13. Gruessner A. Update on pancreas transplantation: comprehensive trend analysis of 25,000 cases followed up over the course of twenty-four years at the international pancreas transplant registry (IPTR). Rev. Diabetes Stud. 2011, 8:6-16.
14. White S.A., Shaw J.A., Sutherland D.E.R. Pancreas transplantation. Lancet 2009, 373:1808-1817.
15. Stegall M.D., Dean P.G., Sung R. The rationale for the new deceased donor pancreas allocation schema. Transplantation 2007, 83:1156-1161.
16. Lacy P.E., Kostianovsky M. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 1967, 16:35-39.
17. Bosco D., Meda P. Reconstructing islet function in vitro. Adv. Exp. Med. Biol. 1997, 426:285-298.
18. Shapiro A.M.J., Lakey J.R.T., Ryan E.A., Korbutt G.S., Toth E., Warnock G.L., Kneteman N.M., Rajotte R.V. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. NEJM 2000, 343:230-238.
19. Roche Diagnostics GmbH Liberase http://www.roche-applied-science.com.
20. CITR (Collaborative Islet Transplant Registry) 2009 Annual Report Dec 2009, (http://www.citregistry.org).
21. Tuch B.E., Keogh G.W., Williams L.J., Wu W., Foster J.L., Vaithilingam V., Philips R. Safety and viability of microencapsulated human islets transplanted into diabetic humans. Emerg. Treat. Technol. 2009, 32:1887-1889.
22. Scharp D.W., Lacy P.E., Santiago J.V., McCullough C.S., Weide L.G., Falqui L., Marchetti P., Gingerich R.L., Jaffe A.S., Cryer P.E. Insulin independence after islet transplantation into type I diabetic patient. Diabetes 1990, 39:515-518.
23. CITR (Collaborative Islet Transplant Registry) Seventh Annual Report Dec 2011, (http://www.citregistry.org).
24. Shapiro A.M.J., Ricordi C., Hering B.J., Auchincloss H., Lindblad R., Robertson P., Secchi A., Brendel M.D., Berney T., Brennan D.C., Cagliero E. International trial of the Edmonton protocol for islet transplantation. NEJM 2006, 355:1318-1330.
25. CITR (Collaborative Islet Transplant Registry) Fifth Annual Report Sept 2008, (http://www.citregistry.org).
26. Shapiro A.M.J., Gallant H.L., Hao E.G., Lakey J.R.T., McCready T., Rajotte R.V., Yatscoff R.W., Kneteman N.M. The portal immunosuppressive storm - relevance to islet transplantation. Ther. Drug Monit. 2005, 27:35-37.
27. Eich T., Eriksson O., Sundin A A. Positron emission topography: a real time tool to quantify early islet engraftment in a preclinical large animal model. Transplantation 2007, 84:893-898.
28. Jansson L., Carlsson P.O. Graft vascular function after transplantation of pancreatic islets. Diabetologia 2002, 45:749-755.
29. Hiscox A.M., Stone A.L., Limesand S., Hoying J.B., Williams S.K. An islet-stabilizing implant constructed using a preformed vasculature. Tissue Eng. A 2008, 14:433-440.
30. Liu Y., Petreaca M., Martins-Green M. Cell and molecular mechanisms of insulin-induced angiogenesis. J. Cell. Mol. Med. 2008, 12:1-13.
31. Stock U.A., Vacanti J.P. Tissue engineering: current state and prospects. Annu. Rev. Med. 2001, 52:443-450.
32. Amory B., Mourmeaux J.L., Remacle C. In vitro cytodifferentiation of perinatal rat islet cells within a tridimensional matrix of collagen. In Vitro Cell. Dev. Biol. 1988, 24:91-96.
33. Brendel M.D., Kong S.S., Alejandro R., Mintz D.J. Improved functional survival of human islets of Langerhans in three-dimensional matrix culture. Cell Transplant 1994, 3:427-433.
34. Beattie G.M., Montgomery A.M., Lopez A.D., Hao E., Perez B., Just M.L., Lakey J.R., Hart M.E., Hayek A. A novel approach to increase human islet cell mass while preserving beta-cell function. Diabetes 2002, 51:3435-3439.
35. Hyder A., Laue C., Schrezenmeir J. Effect of the immunosuppressive regime of Edmonton protocol on the long-term in vitro insulin secretion from islets of two different species and age categories. Toxicol. in Vitro 2005, 19:541-546.
36. Lim F., Sun AM A.M. Microencapsulated islets as bioartificial endocrine pancreas. Science 1980, 210:908-910.
37. Orive G., Hernandez R.M., Gascon A.R., Calafiore R., Chang T.M.S., de Vos P., Hortelano G., Hunkeler D., Lacik I., Pedraz J.L. History, challenges and perspectives of cell microencapsulation. Trends Biotechnol. 2004, 22:87-92.
38. Zimmermann H., Zimmermann D., Reuss R., Feilen P.J., Manz B., Katsen A., Weber M., Ihmig F.R., Ehrhart F., Geßner P., Behringer M. Towards a medically approved technology for alginate based microcapsules allowing long term immunoisolated transplantation. J. Mater. Sci. 2005, 16:491-501.
39. Omer A., Duvivier-Kali V., Fernandes J. Long-term normoglycemia in rats receiving transplants with encapsulated islets. Transplantation 2005, 79:52-58.
40. Hoesli C.A., Kiang R.L.J., Mocinecova D., Speck M., Jochec Moskova D., Donald-Hague C., Lacik I., Kieffer T.J., Piret J.M. Reversal of diabetes by βTC3 cells encapsulated in alginate beads generated by emulsion and internal gelation. J. Biomed. Mater. Res. B Appl. Biomater. 2012, 100B:1017-1028.
41. de Vos P., Faas M.M., Strand B., Calafiore R. Alginate-based microcapsules for immunoisolation of pancreatic islets. Biomathematics 2006, 27:5603-5617.
42. Dugas V., Beauchamp C., Hallé J.P., Lesage S. Protection by microencapsulation from antigen recognition, immune cells, antibodies, and compliment components. The Bioartificial Pancreas and Other Biohybrid Techniques 2009, 261-277. Transworld Research Network, Kerala, India. J.P. Hallé, P. de Vos, L. Rosenberg (Eds.).
43. Chang T.M.S. Semipermeable microcapsules. Science 1964, 524-525.
44. de Vos P., Andersson A., Tam S.K., Fass M., Hallé J.P. Advances and barriers in mammalian cell encapsulation for treatment of diabetes. Immunol. Endocrinol. Metab. Agents Med. Chem. 2006, 6:139-153.
45. Robitaille R., Dusseault J., Henley N., Rosenberg L., Hallé J.P. Insulin-like growth factor II allows prolonged blood glucose normalization with a reduced islet cell mass transplantation. Endocrinology 2003, 144:3037-3045.
46. de Vos P., Faas M.M., Strand B., Calafiore R. Alginate-based microcapsules for immunoisolation of pancreatic islets. Biomathematics 2006, 27:5603-5617.
47. Zekorn T., Siebers U., Horcher A., Schnettler R., Klöck G., Bretzel R.G., Zimmermann U., Federlin K. Barium-alginate beads for immunoisolated transplantation of islets of Langerhans. Trans. Proc. 1992, 24:937-939.
48. Mueller-Klieser W.E., Sutherland R.M. Influence of convection in the growth medium on oxygen tensions in multicellular tumor spheroids. Cancer Res. 1982, 42:237-242.
49. Poncelet D., Tam S.K. Microencapsulation Technologies for a Bioartifical Endocrine Pancreas. The Bioartificial Pancreas and Other Biohybrid Techniques 2009, 37-50. Transworld Research Network, Kerala, India. J.P. Hallé, P. de Vos, L. Rosenberg (Eds.).
50. Poncelet D., Neufeld R.J., Goosen M.F.A., Burgarski B., Babak V. Formation of microgel beads by electric dispersion of polymer solutions. AIChE J 1999, 45:2018-2023.
51. Serp D., Cantana E., Heinzen C., von Stockar U., Marison I.W. Characterization of an encapsulation device for the production of monodisperse alginate beads for cell immobilization. Biotechnol. Bioeng. 2000, 70:41-53.
52. Prusse U., Jahnz P., Wittlich J., Breford J. K.D Vorlop, Bead Production with JetCutting and Rotating Disc/Nozzle Technologies. Practical aspects of encapsulation technologies 2002, 1-10. Bundesforschungsanstalt Landwirtschaft, Braunschweig, Germany. U. Prusse, K.D. Vorlop (Eds.).
53. Strutt J.W., Rayleigh J.W.S. On the instability of jets, 1878. Proc. Lond. Math. Soc. 1878, 10:4-13.
54. Poncelet D., Lencki R., Beaulie C., Neufeld R.J. Production of alginate beads by emulsification/internal gelation. I. Methodology. Appl. Microbiol. Biotechnol. 1992, 38:39-45.
55. Poncelet D., Poncelet De Smet B. B, C. Beaulieu, M.L. Huguet, A. Fournier, R.J. Neufeld. Production of alginate beads by emulsion/internal gelation. II. Physicochemistry. Appl. Microbiol. Biotechnol. 1995, 43:644-650.
56. Hoesli C.A., Raghuram K., Kiang R.L.J., Mocinecova D., Hu X., Johnson J.D., Lacik I., Kieffer T.J., Piret J.M. Pancreatic cell immobilization in alginate beads produced by emulsion and internal gelation. Biotechnol. Bioeng. 2011, 108:424-434.
57. Robitaille R., Hallé J.P. Characterisation and Evaluation of the Properties and Functions of the Microcapsules. The Bioartificial Pancreas and Other Biohybrid Techniques 2009, 67-85. Transworld Research Network, Kerala, India. J.P. Hallé, P. de Vos, L. Rosenberg (Eds.).
58. Thu B., SkjakBraek G., Micali F., Vittur F., Rizzo R. The spatial distribution of calcium in alginate gel beads analysed by synchrotronradiation induced X-ray emission (SRIXE). Carbohydr. Res. 1997, 297:101-105.
59. Cheng J.Y.C., Rughunath M., Whitelock J., Poole-Warren L. Matrix components and scaffolds for sustained islet function. Tissue Eng. B 2011, 17:235-247.
60. Weber L.M., Hayda K.N., Anseth K.S. Cell-matrix interactions improve β-cell survival and insulin secretion in three-dimensional culture. Tissue Eng. A 2008, 14:1959-1967.
61. Daoud J., Petropavlovskaia M., Rosenberg L., Tabrizian M. The effect of extracellular matrix components on the preservation of human islet function in vitro. Biomaterials 2010, 31:1676-1682.
62. Del Guerra C., Bracci K. Nilsson, entrapment of dispersed pancreatic islet cells in CultiSpher-S macroporous gelatin microcarriers. Biotechnol. Bioeng. 2001, 75:741-744.
63. Landers R., Pfister A., Hubner U., Schmelzeisen R., Mulhaupt R. Fabrication of Soft Tissue Engineering Scaffolds by Means of Rapid Prototyping Techniques 2002, 37:3107-3116.
64. Lucas-Clerc C., Massart C., Campion J.P. Long-term culture of human pancreatic islets in an extracellular matrix: morphological and metabolic effects. Mol. Cell. Endocrinol. 1993, 94:9-14.
65. Chun S., Huang Y., Xiw W.J. Adhesive growth of pancreatic islet cells on a PGA fibrous scaffold. Trans. Proc. 2008, 40:1658-1663.
66. Salvay D.M., Rives C.B., Zhang X., Chen F., Kaufman D.B., Lowe W.L., Shea L.D. Extracellular matrix protein-coated scaffolds promote the reversal of diabetes after extrahepatic islet transplantation. Transplantation 2008, 85:1456-1464.
67. Hou Y., Song C., Xie W.J., Wei Z., Huang R.P., Liu W., Zhang Z.L., Shi Y.B. Excellent effect of three-dimensional culture condition on pancreatic islets. Diabetes Res. Clin. Pract. 2009, 86:11-15.
68. Kawazoe N., Lin X., Tateishi T. Three-dimensional cultures of rat pancreatic RIN-5F cells in porous PLGA-collagen hybrid scaffolds. J. Bioact. Compat. Polym. 2009, 24:25-42.
69. Jiang F.X., Naselli G., Harrison L.C. Distinct distribution of laminin and its integrin receptors in the pancreas. J. Histochem. Cytochem. 2002, 50:1625-1632.
70. Hamamoto Y., Fujimoto S., Inada A. Beneficial effect of pretreatment of islets with fibronectin on glucose tolerance after islet transplantation. Horm. Metab. Res. 2003, 35:460-465.
71. Kaido T., Yebra M., Cirulli V. Regulation of human beta-cell adhesion, motility, and insulin secretion by collagen IV and its receptor alpha1 beta1. J. Biol. Chem. 2004, 279:53762-53769.
72. Daoud J.T., Petropavlovskaia M.S., Patapas J.M., Degrandpré C.E., DiRaddo R.W., Rosenberg L., Tabrizian M. Long-term in vitro human pancreatic islet culture using three-dimensional microfabricated scaffolds. Biomaterials 2011, 32:1536-1542.
73. Steele J.A.M., Barron A.E., Carmona E., Hallé J.-P., Neufeld R.J. Encapsulation of protein microfiber networks supporting pancreatic islets. J. Biomater. Mater. Res. A 2012, 100:3384-3391.
74. Smidsrød O., Skjåk-Braek G. Alginate as immobilization matrix for cells. Trends Biotechnol. 1990, 8:71-78.
75. Mallet A.G., Korbutt G.S. Alginate modification improves long-term survival and function of transplanted encapsulated islets. Tissue Eng. A 2009, 15:1301-1309.
76. de Vos P., Bucko M., Gemeiner P., Navratil M., Svitel J., Faas M., Strand B.L., Skjak-Braek G., Morch Y.A., Vikartovska A., Lacik I., Kollarikova G., Orive G., Poncelet D., Pedraz J.L., Ansorge-Schumacher M.B. Multiscale requirements for bioencapsulation in medicine and biotechnology. Biomaterials 2009, 30:2559-2570.
77. Langlois G., Dusseault J., Bilodeau S., Tam S.K., Magassouba D., Hallé J.P. Direct effect of alginate purification on the survival of islets immobilized in alginate-based microcapsules. Acta Biomater. 2009, 5:3433-3440.
78. Ménard M., Dusseault J., Langlois G., Baille W.E., Tam S.K., Yahia L.H., Zhu X.X., Hallé J.P. Role of protein contaminants in the immunogenicity of alginates. J. Biomed. Mater. Res. B 2010, 93:333-340.
79. Monaco A.P., Maki T., Ozato H., Carretta M., Sullivan S.J., Borland K.M., Mahoney M.D., Chick W.L., Muller T.E., Wolfrum J., Solomon B. Transplantation of islet allografts and xenografts in totally pancreatectomized diabetic dogs using the hybrid artificial pancreas. Ann. Surg. 1991, 214:339-362.
80. de Vos P., de Haan B.J., Faas M.M. Different Approaches for Immunoisolation. The Bioartificial Pancreas and Other Biohybrid Techniques 2009, 27-36. Transworld Research Network, Kerala, India. J.P. Hallé, P. de Vos, L. Rosenberg (Eds.).
81. Sandler S., Eizirik D.L., Sternesjo J., Welsh N. Role cytokines in regulation of pancreatic b-cell function. Biochem. Soc. Trans. 1994, 22:26-30.
82. Leblond F.A., Simard G., Henley N., Rocheleau B., Huet P.M., Hallé J.P. Studies on smaller (similar to 315μm) microcapsules: IV feasibility and safety of intrahepatic implantations of small alginate poly-l-lysine microcapsules. Cell Transplant. 1999, 8:327-337.
83. de Vos P., Hamel A.F., Tatarkiewicz K. Considerations for successful transplantation of encapsulated pancreatic islets. Diabetologia 2002, 45:159-173.
84. Muthyala S., Raj V.R.R., Mohanty M., Mohanan P.V., Nair P.D. The reversal of diabetes in rat model using mouse insulin producing cells - a combination approach of tissue engineering and macroencapsulation. Acta Biomater. 2011, 7:2153-2162.
85. Townsend-Nicholson A., Jayasinghe S.N. Cell electrospinning: a unique biotechnique for encapsulating living organisms for generating active biological microthreads/scaffolds. Biomacromology 2006, 7:3364-3369.
86. Onoe H., Okitsu T., Itou A., Kato-Negishi M., Gojo R., Kiriya D., Sato K., Miura S., Iwanaga S., Kuribayashi-Shigetomi K., Matsunaga Y.T., Shimoyama Y., Takeuchi S. Metre-long cell-laden microfibers exhibit tissue morphologies and functions. Nat. Mater. 2013, 12:584-590.
87. Calafiore R., Basta G., Luca G., Lemmi A., Montanucci M.P., Calabrese G., Racanicchi L., Manusco F., Brunetti P. Microencapsulated pancreatic islet allografts into nonimmuno-suppressed patients with type 1 diabetes. Emerg. Treat. Technol. 2006, 29:137-138.
88. Calafiore R., Basta G., Luca G., Lemmi A., Montanucci M.P., Racanicchi L., Manusco F., Brunetti P. Standard technical procedures for microencapsulation of human islets for graft into nonimmunosuppressed patients with type 1 diabetes mellitus. Transplant. Proc. 2006, 38:1156-1157.
89. http://clinicaltrials.gov/ct2/show/NCT00940173.
90. http://www.lctglobal.com/Products-and-Services/Diabecell.
91. http://viacyte.com/products/vc-01-diabetes-therapy.
92. http://clinicaltrials.gov/ct2/show/NCT00260234.
93. http://www.prnewswire.com/news-releases/novocell-becomes-viacyte-inc-as-it-accelerates-pre-clinical-development-of-a-stem-cell-derived-treatment-for-diabetes-92923104.html.
94. http://clinicaltrials.gov/ct2/show/record/NCT01379729.
95. http://clinicaltrials.gov/ct2/show/NCT00790257.